Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals Stock Forecast

Stock Price Forecast

The 22 analysts that cover Ionis Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $85.91, which forecasts a 8.17% increase in the stock price over the next year. The lowest target is $39 and the highest is $110.

Price Target: $85.91 (+8.17%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$39	$85.91	$94	$110
Change	-50.89%	+8.17%	+18.36%	+38.50%

Analyst Ratings

The average analyst rating for Ionis Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	9	9	9	9	9	9
Buy	8	8	9	9	9	9
Hold	4	4	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	21	21	22	22	22	22

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mani Foroohar Leerink Partners	Leerink Partners	Buy Maintains $102 → $104	Buy	Maintains	$102 → $104	+30.95%	Mar 3, 2026
Allison Bratzel Piper Sandler	Piper Sandler	Buy Maintains $87 → $100	Buy	Maintains	$87 → $100	+25.91%	Feb 27, 2026
Paul Matteis Stifel	Stifel	Hold Maintains $73 → $77	Hold	Maintains	$73 → $77	-3.05%	Feb 26, 2026
Joseph Stringer Needham	Needham	Strong Buy Maintains $90 → $103	Strong Buy	Maintains	$90 → $103	+29.69%	Feb 26, 2026
Allison Bratzel Piper Sandler	Piper Sandler	Buy Maintains $77 → $87	Buy	Maintains	$77 → $87	+9.54%	Feb 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

852.60M

Decreased by -9.65%

from 943.71M

Revenue Next Year

1.42B

Increased by 66.43%

from 852.60M

EPS This Year

-3.88

from -2.38

EPS Next Year

-1.50

from -3.88

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	810.46M	587.37M	787.65M	705.14M	943.71M	852.60M	1.42B
Revenue Growth	11.13%	-27.53%	34.10%	-10.48%	33.83%	-9.65%	66.43%
EPS	-0.20	-1.90	-2.56	-3.04	-2.38	-3.88	-1.50
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	25	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	1.0B	2.1B
Avg	852.6M	1.4B
Low	673.1M	970.0M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	8.7%	144.0%
Avg	-9.7%	66.4%
Low	-28.7%	13.8%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-2.89	2.10
Avg	-3.88	-1.50
Low	-4.60	-3.88

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.